ES
LABORATORIOS
OJER PHARMA

INNOVATION AS A PHILOSOPHY
COLLABORATIVE
NETWORKS

ALWAYS SEARCHING FOR EXCELLENCE
COLLABORATIVE
NETWORKS

BUILDING STRONG RELATIONSHIPS WITH OUR PARTNERS AND COLLABORATORS
COLLABORATIVE
NETWORKS

BELIEVING IN PEOPLE AS A FUNDAMENTAL PART FOR PROGRESS
COLLABORATIVE
NETWORKS

RESEARCH AND DEVELOPMENT TO PROVIDE BETTER SOLUTIONS

Who we are

Laboratorios Ojer Pharma is a New Technology-Based Company (NEBTs) that focuses all its efforts on the development of innovative pharmaceutical products to provide real solutions in dermatology. Our expertise is the research and development of innovative pharmaceutical forms to improve the properties of the conventional formulations and ameliorate the current therapeutic options.

What we offer?

Develop new products and delivery technologies
through collaborative projects.

What we look for?

Strategic partners interested in expanding and completing their dermatological product portfolio with innovative and attractive products.

ABOUT US

NEWS

EU-Japan Center

HORIZON 2020 SEAL OF EXCELLENCE

Due to its innovative properties, the European Comission, as the institution managing the Programme Horizon 2020, granted the seal of excellence to Laboratorios Ojer Pharma for a Project based on its vehiculization technology in form of bioadhesive gels.

Gobierno de España. Ministerio de Economía y Competitividad

FUNDING GRANTED
TO THE PROJECT KERAMOD

The State Secretariat for Research, Development and Innovation granted funding for the development of the project called “cooperative development of a drug in the form of sustained-release matrix for the treatment of basal cell carcinoma” presented in the call Retos-Colaboración 2014 (RTC-2014-2068-1).

Funding granted to the project Proderma

FUNDING GRANTED
TO THE PROJECT PRODERMA

The State Secretariat for Research, Development and Innovation granted funding for the Development of the Project called “Development of a sustained- release matrix for the treatment of Diabetic Foot Ulcers (DFU)” presented in the call Retos-Colaboración 2015 (RTC-2015-3466-1).

Technology

MEDICINES FOR
SKIN CARE

Ojer Pharma has developed an innovative platform of bioadhesive gels with important competitive advantages.
Our patented technology has been applied to:

Patents

REQUESTED IN PROCESS GRANTED
AMERICA 05 01 02
EUROPE 00 00 09
AFRICA 01 00 01
ASIA 06 02 03
OCEANIA 01 02 01

KEY ACTIVITIES

We carry out all the R&D process from
Business intelligence to Open innovation

01 BUSINESS
INTELLIGENCE
02 PHARMACEUTICAL
DEVELOPMENT
03 NON-CLINICAL
DEVELOPMENT
04 CLINICAL
DEVELOPMENT
05 REGULATORY
STRATEGY
06 OPEN
INNOVATION
COLLABORATIVE
NETWORKS
UNIVERSIDAD
DE NAVARRA

Interschool departments teach in the Faculty of Pharmacy Science and Medicine and collaborate with the Center for Applied Medical Research (CIMA), the Center for Applied Medical Pharmacobiology (CIFA) and the Clínica Universidad de Navarra (CUN).

SEE MORE
COLLABORATIVE
NETWORKS
UNIVERSIDAD
DE BARCELONA

The UB, through the Pharmacy Faculty, and managed by the Fundación Bosch I Gimpera (FBIG), set up the Service of Development of Medicines (SDM) to make the necessary collaboration between the university and the pharmaceutical industry possible.

SEE MORE